Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103665064B details a novel three-step synthesis for high-purity sugar intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN113461743A reveals a cost-effective 4-step route for crosslinkable nucleosides, eliminating chromatography and enabling high-purity oligonucleotide manufacturing.
Novel patent CN103087121B offers high-purity IPTG synthesis without toxic mercaptans, ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN116217633B details chemical synthesis avoiding enzymes. Enables scalable production and cost reduction for nutritional ingredient supply chains.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.
Patent CN108239128A reveals TMSOTf catalysis for high-purity beta-nucleosides. Enhances supply chain reliability and cost reduction in pharma manufacturing.
Patent CN111072734A reveals a high-yield route to Doxifluridine using a styryl-benzoate ribose donor, offering mild conditions and 98% coupling efficiency for API manufacturing.
Patent CN10494545451B reveals high-yield glycosylation route. Eliminates heavy metals for cost reduction and supply reliability in pharmaceutical intermediate manufacturing.
Patent CN107573311A reveals a cost-effective Dapagliflozin route using 4-methylphenol. This method ensures high purity and scalable manufacturing for global supply chains.
Patent CN109912642A enables high-purity pharmaceutical intermediates via novel protecting group strategy ensuring supply chain reliability and cost efficiency for global buyers.
Novel 3-step synthesis of Cytosine Nucleoside from cyanoacetaldehyde urea acetal. High yield, cost-effective route for antiviral API manufacturing.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN108440623A reveals a novel silylation-free route for Capecitabine Intermediate. Achieve higher purity and reduced manufacturing costs with scalable supply.
Patent CN108610386A reveals a scalable synthesis for hexuronic acid glycosides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with our advanced catalytic process.
Patent CN108373491B reveals a cost-effective chemical route for nelarabine using cyclocytidine and TMSOTf catalysis, offering significant supply chain advantages.
Patent CN115073540A reveals a modular chemical synthesis for high-purity inulin-type fructooligosaccharides, offering superior supply chain reliability and cost efficiency.
Patent CN113861246B introduces a novel stereoselective synthesis method enhancing purity and yield for pharmaceutical intermediates, offering significant supply chain and cost advantages.
Novel cobalt-catalyzed method for diabetes drug intermediates. Reduces cost and improves supply chain reliability significantly for global buyers seeking scalable solutions.
Patent CN103122012B reveals a streamlined synthesis for fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN100488977C details a high-yield cytidine synthesis route offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.